As an early-stage experimental drug, very little ZMapp existed before the outbreak. Questions remain about how much is left. Earlier this month, Mapp issued a statement saying supplies had run out. Yet this week news broke about ZMapp being used to treat another patient, this time a British nurse.
www.kpbs.org/news/2014/aug/27/san-diego-company-breaks-silence-experimental-ebol/